Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Sunrise › NPI 1023586260
Lab

Molecular Stat Laboratory, INC.

Molecular Stat Laboratory, INC. was paid $6.25M by Medicaid between Jul 2020 and Feb 2023, across 11 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 74% of everything it billed.

33Billing provider infoMOLECULAR STAT LABORATORY, INC.
SUNRISE, FL 33351
33aNPI1023586260assigned 11/06/2018
28Total paid$6.25M
24GClaims162,324
24DCodes billed11
24AFirst – last monthJul 2020 – Feb 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#12 of 225
Median peer was paid$74K
This provider vs. median85×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020890$1K
2021890$4K
2022159,626$6.22M
2023918$24K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 74% 73,004 33,257 $4.61M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 25% 72,438 32,943 $1.53M
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.7% 7,105 5,908 $104K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 82 61 $4K
80053 Comprehensive metabolic panel <1% 219 144 $212.85
80061 Lipid panel <1% 204 139 $71.23
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 258 164 $43.48
83036 Hemoglobin; glycosylated (A1C) <1% 227 147 $28.10
36415 Collection of venous blood by venipuncture <1% 484 307 $21.16
99000 0% 8,211 6,942 $0.00
84443 Thyroid stimulating hormone (TSH) 0% 92 58 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHALL, FREDDY (OWNER)